Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TTR | P02766 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11677753 | 0.89 | ALDH1A1 (0.50) | ALDH1A1CYP3A4LMNAGPR35PDE7A | |
| SCHEMBL2436697 | 0.86 | ALDH1A1 (0.62) | ALDH1A1CYP3A4LMNATDP1PDE7A | |
| SCHEMBL11649757 | 0.84 | ALDH1A1 (0.50) | ALDH1A1CYP3A4GPR35TDP1PDE7A | |
| SCHEMBL12583947 | 0.84 | ALDH1A1 (0.54) | ALDH1A1CYP3A4LMNATDP1PDE7A | |
| SCHEMBL9173191 | 0.82 | ALDH1A1 (0.72) | ALDH1A1CYP3A4LMNATDP1HIF1A | |
| SCHEMBL8902847 | 0.82 | ALDH1A1 (0.53) | ALDH1A1CYP3A4LMNATDP1PDE7A | |
| SCHEMBL21653949 | 0.82 | ALDH1A1 (0.58) | ALDH1A1CYP3A4LMNAGPR35TDP1 | |
| SCHEMBL28375616 | 0.82 | ALDH1A1 (0.49) | ALDH1A1CYP3A4LMNAGPR35TDP1 | |
| SCHEMBL30152587 | 0.82 | ALDH1A1 (0.53) | ALDH1A1CYP3A4LMNATDP1PDE7A | |
| SCHEMBL2313846 | 0.82 | ALDH1A1 (0.53) | ALDH1A1CYP3A4LMNATDP1PDE7A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080317806-A1 | Antiparasitic Compounds | MURDOCH UNIVERSITY (AU) | 2008-12-25 | — | — | US | claimed |
| EP-1871743-A1 | ANTIPARASITIC COMPOUNDS | Murdoch University (AU) | 2008-01-02 | — | — | EP | claimed |
| WO-2006108224-A1 | ANTIPARASITIC COMPOUNDS | MURDOCH UNIVERSITY (AU) | 2006-10-19 | — | — | WO | claimed |
| EP-0287329-B1 | Chromogenic cryptahemispherands useful in detecting electrolytes | MILES INC (US) | 1993-12-08 | — | — | EP | claimed |
| US-5177221-A | Chromogenic hemispherands and their preparation | MILES INC. (US) | 1993-01-05 | — | — | US | claimed |
| US-5011924-A | Measurement Of Ions | TECHNICON INSTRUMENTS CORPORATION (US) | 1991-04-30 | — | — | US | claimed |
| US-4992381-A | Method of detecting electrolytes in an aqueous test sample using chromogenic hemispherands and test device therefor | TECHNICON INSTRUMENTS CORPORATION (US) | 1991-02-12 | — | — | US | claimed |
| US-4859606-A | Method for detecting cations in a test sample utilizing chromogenic cryptahemispherands | TECHNICON INSTRUMENTS CORPORATION (US) | 1989-08-22 | — | — | US | claimed |
| EP-0287330-A2 | Chromogenic hemispherands useful for detecting electrolytes | Bayer Corporation (US) | 1988-10-19 | — | — | EP | claimed |
| EP-0287329-A2 | Chromogenic cryptahemispherands useful in detecting electrolytes | Bayer Corporation (US) | 1988-10-19 | — | — | EP | claimed |
| EP-0000156-B1 | 2-ARYLAMINO-3,5-DINITRO-BENZOTRIFLUORIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES. | BAYER AG (DE) | 1980-11-12 | — | — | EP | claimed |
| EP-0000156-A1 | 2-Arylamino-3,5-dinitro-benzotrifluorides, process for their preparation and their use as pesticides. | BAYER AG (DE) | 1979-01-10 | — | — | EP | claimed |
| US-20250115927-A1 | METHODS FOR CLONAL PLANT PRODUCTION | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2025-04-10 | — | — | US | disclosed |
| US-20250101453-A1 | METHODS OF PARTHENOGENIC HAPLOID INDUCTION AND HAPLOID CHROMOSOME DOUBLING | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2025-03-27 | — | — | US | disclosed |
| US-12146147-B2 | Methods for clonal plant production | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2024-11-19 | — | — | US | disclosed |
| WO-2022128850-A1 | NOVEL ISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES | GALAPAGOS NV (BE) | 2022-06-23 | — | — | WO | disclosed |
| EP-0000156-A1 | 2-Arylamino-3,5-dinitro-benzotrifluorides, process for their preparation and their use as pesticides. | BAYER AG (DE) | 1979-01-10 | — | — | EP | disclosed |
| EP-0000156-A1 | 2-Arylamino-3,5-dinitro-benzotrifluorides, process for their preparation and their use as pesticides. | BAYER AG (DE) | 1979-01-10 | — | — | EP | disclosed |
| US-4059402-A | SUBLIMATION, MONOAZO DYES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-22 | — | — | US | disclosed |
| US-4056523-A | SULFONAMIDO SUBSTITUTED | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080317806-A1 | Antiparasitic Compounds | CYCS, CBR3, CBR1 | ALDH1A1 2244/4885CYP3A4 441/4885LMNA 2565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.